Stephens Inc’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,975
Closed -$110K 1284
2025
Q1
$110K Sell
11,975
-14,800
-55% -$148K ﹤0.01% 1172
2024
Q4
$281K Sell
26,775
-28,925
-52% -$342K ﹤0.01% 1045
2024
Q3
$666K Sell
55,700
-28,325
-34% -$245K 0.01% 728
2024
Q2
$483K Sell
84,025
-31,800
-27% -$174K 0.01% 813
2024
Q1
$602K Sell
115,825
-26,850
-19% -$131K 0.01% 737
2023
Q4
$752K Sell
142,675
-8,800
-6% -$34.8K 0.01% 608
2023
Q3
$500K Sell
151,475
-121,121
-44% -$425K 0.01% 726
2023
Q2
$788K Sell
272,596
-37,225
-12% -$71.4K 0.01% 605
2023
Q1
$332K Sell
309,821
-29,605
-9% -$56.6K 0.01% 847
2022
Q4
$886K Sell
339,426
-24,225
-7% -$106K 0.02% 531
2022
Q3
$2.55M Buy
363,651
+22,750
+7% +$178K 0.05% 321
2022
Q2
$2.33M Buy
340,901
+106,555
+45% +$1.09M 0.05% 340
2022
Q1
$3.3M Buy
234,346
+49,760
+27% +$666K 0.05% 333
2021
Q4
$2.67M Buy
+184,586
New +$2.62M 0.04% 393

Other funds holding BVS